Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2003-2017
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2021
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
18
- Prescription drug price development in the U.S. by select drug 2010-2017
- Change in employment in selected U.S. manufacturing industries 2008-2018
- Share of sales outside Denmark of Novo Nordisk 2008-2023
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Dividends paid by Novartis AG 2009-2023
- U.S. pharma industry R&D expenditure 1980-2022
- Operating profit of Novo Nordisk 2009-2023
- Bristol-Myers Squibb's revenue by region 2010-2023
- Leading global pharmaceutical risers based on share price 2022
- Global pharmaceutical R&D spending vs US and China 2014-2023
- Bristol-Myers Squibb's employee number 2015-2023
- Demand growth in select countries for immunoglobulin 2018
- U.S. healthcare: consumer responses to viewing advertisements for medicines
- Increase in research collaborations between 2005 and 2014 U.S. by type
- Common ways to purchase prepared Chinese medicine in China 2020
- Main reasons to purchase prepared Chinese medicine in China 2020
- Employees at Jazz Pharmaceuticals 2021-2023, by region
- Oral health care market size in China 2016-2025
Further Content: You might find this interesting as well
Statistics
- Prescription drug price development in the U.S. by select drug 2010-2017
- Change in employment in selected U.S. manufacturing industries 2008-2018
- Share of sales outside Denmark of Novo Nordisk 2008-2023
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Dividends paid by Novartis AG 2009-2023
- U.S. pharma industry R&D expenditure 1980-2022
- Operating profit of Novo Nordisk 2009-2023
- Bristol-Myers Squibb's revenue by region 2010-2023
- Leading global pharmaceutical risers based on share price 2022
- Global pharmaceutical R&D spending vs US and China 2014-2023
- Bristol-Myers Squibb's employee number 2015-2023
- Demand growth in select countries for immunoglobulin 2018
- U.S. healthcare: consumer responses to viewing advertisements for medicines
- Increase in research collaborations between 2005 and 2014 U.S. by type
- Common ways to purchase prepared Chinese medicine in China 2020
- Main reasons to purchase prepared Chinese medicine in China 2020
- Employees at Jazz Pharmaceuticals 2021-2023, by region
- Oral health care market size in China 2016-2025
PhRMA. (December 15, 2020). Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2003-2017 [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/240032/randd-expenditure-per-employee-in-us-sectors/
PhRMA. "Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2003-2017." Chart. December 15, 2020. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/240032/randd-expenditure-per-employee-in-us-sectors/
PhRMA. (2020). Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2003-2017. Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/240032/randd-expenditure-per-employee-in-us-sectors/
PhRMA. "Pharmaceutical R&d Expenditure per Employee Compared to Other U.S. Manufacturing Sectors 2003-2017." Statista, Statista Inc., 15 Dec 2020, https://www.statista.com/statistics/240032/randd-expenditure-per-employee-in-us-sectors/
PhRMA, Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2003-2017 Statista, https://www.statista.com/statistics/240032/randd-expenditure-per-employee-in-us-sectors/ (last visited June 10, 2024)
Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2003-2017 [Graph], PhRMA, December 15, 2020. [Online]. Available: https://www.statista.com/statistics/240032/randd-expenditure-per-employee-in-us-sectors/